EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, GOVX: Geovax Labs

27 Oct 25 15:59
LAST:

0.5725

CHANGE:
 0.01		OPEN:
0.5668		HIGH:
0.5800		ASK:
0.0000		VOLUME:
366.3K
CHG(%):
1.08		PREV:
0.5665		LOW:
0.5600		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
27 Oct 250.57530.58000.56000.5726387.9K
24 Oct 250.57260.57280.54840.5665683.9K
23 Oct 250.53500.54880.52210.5401311.0K
22 Oct 250.57880.57880.52500.5322864.6K
21 Oct 250.59000.60290.56600.5789540.1K
20 Oct 250.55440.61000.55440.5976867.4K
17 Oct 250.54000.56200.54000.5525554.5K
16 Oct 250.60000.63000.56000.56212.21M
15 Oct 250.60000.61000.59010.5967597.1K
14 Oct 250.55000.61590.54500.60431.46M

COMPANY PROFILE

Name:Geovax Labs
About:GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Sector:Healthcare
Industry:Biotechnology
Address:1900 Lake Park Drive, Smyrna, GA, United States, 30080
Website:https://www.geovax.com
CUSIP:373678408
CIK:0000832489
ISIN:US3736786068
FIGI:BBG000BGGJD8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.562.6%
MA10:0.570.4%
MA20:0.561.6%
MA50:0.6513.3%
MA100:0.7327.3%
MA200:1.0482.1%
STO9:41.31
STO14:41.31
RSI14:52.91
WPR14:-43.97
MTM14:-0.01
ROC14:-0.02 
ATR:0.04 
Week High:0.616.6%
Week Low:0.529.7%
Month High:0.6717.4%
Month Low:0.4682.1%
Year High:3.88577.7%
Year Low:0.4333.1%
Volatility:6.14 

RECENT SPLITS

Date Ratio
31 Jan 20241-15
25 Sep 20201-20